Company Overview of Glaxosmithkline Biologicals S.A.
Glaxosmithkline Biologicals S.A. researches, develops, manufactures, and supplies vaccines. Its vaccination products are used to tackle various diseases, such as rabies, diphtheria, tetanus, and yellow fever, as well as polio, measles, mumps, and rubella and hepatitis B. It has a strategic alliance VBI Vaccines Inc. GlaxoSmithKline Biologicals S.A. with was formerly known as SmithKline Beecham Biologicals S.A. and changed its name to GlaxoSmithKline Biologicals S.A. in 2000. The company was founded in 1945 and is based in Rixensart, Belgium. Glaxosmithkline Biologicals S.A. operates as a subsidiary of GlaxoSmithKline plc.
Rue de l'institut 89
Founded in 1945
32 2 656 81 11
32 2 656 80 00
Key Executives for Glaxosmithkline Biologicals S.A.
Glaxosmithkline Biologicals S.A. Key Developments
Similar Private Companies By Industry
|Apotheek Delestre NV||Europe|
|Apotheek Moons NV||Europe|
|Apotheek Philips NV||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Glaxosmithkline Biologicals S.A., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.